Add to ORKGAzathioprine therapy is discontinued in one-third of patients with inflammatory bowel disease because of toxicity or a lack of clinical response. Patients with thiopurine methyltransferase (TPMT) deficiency are intolerant to azathioprine, whilst carriers are at increased risk of side-effects
TPMT deficiency is associated with azathioprine (AZA)-induced myelosuppression (MS). However, in one...
TPMT deficiency is associated with azathioprine (AZA)-induced myelosuppression (MS). However, in one...
There is a growing interest in the use of thiopurines (azathioprine, 6-mercaptopurine and 6-thioguan...
Azathioprine therapy is discontinued in one-third of patients with inflammatory bowel disease becaus...
Background: Azathioprine therapy is discontinued in one-third of patients with inflammatory bowel di...
Background: Azathioprine therapy is discontinued in one-third of patients with inflammatory bowel di...
BACKGROUND: Azathioprine (AZA), used to treat inflammatory bowel disease (IBD), is metabolized by th...
Thiopurine S-methyltransferase (TPMT) deficient patients develop life threatening haematoxicity (for...
SummaryAzathioprine is an immunosuppressant and cytotoxic pro-drug which acts to impair purine synth...
Inflammatory bowel disease (IBD, i.e. primarily Crohn's disease and ulcerative colitis) is character...
International audienceChronic inflammatory bowel disease (IBD) includes Crohn's disease and ulcerati...
Thiopurines (TP) are widely used in the management of inflammatory bowel diseases. Side effects and ...
Thiopurines (TP) are widely used in the management of inflammatory bowel diseases. Side effects and ...
Thiopurines (TP) are widely used in the management of inflammatory bowel diseases. Side effects and ...
Background: Firm recommendations about the way thiopurine drugs are introduced and the use of thiopu...
TPMT deficiency is associated with azathioprine (AZA)-induced myelosuppression (MS). However, in one...
TPMT deficiency is associated with azathioprine (AZA)-induced myelosuppression (MS). However, in one...
There is a growing interest in the use of thiopurines (azathioprine, 6-mercaptopurine and 6-thioguan...
Azathioprine therapy is discontinued in one-third of patients with inflammatory bowel disease becaus...
Background: Azathioprine therapy is discontinued in one-third of patients with inflammatory bowel di...
Background: Azathioprine therapy is discontinued in one-third of patients with inflammatory bowel di...
BACKGROUND: Azathioprine (AZA), used to treat inflammatory bowel disease (IBD), is metabolized by th...
Thiopurine S-methyltransferase (TPMT) deficient patients develop life threatening haematoxicity (for...
SummaryAzathioprine is an immunosuppressant and cytotoxic pro-drug which acts to impair purine synth...
Inflammatory bowel disease (IBD, i.e. primarily Crohn's disease and ulcerative colitis) is character...
International audienceChronic inflammatory bowel disease (IBD) includes Crohn's disease and ulcerati...
Thiopurines (TP) are widely used in the management of inflammatory bowel diseases. Side effects and ...
Thiopurines (TP) are widely used in the management of inflammatory bowel diseases. Side effects and ...
Thiopurines (TP) are widely used in the management of inflammatory bowel diseases. Side effects and ...
Background: Firm recommendations about the way thiopurine drugs are introduced and the use of thiopu...
TPMT deficiency is associated with azathioprine (AZA)-induced myelosuppression (MS). However, in one...
TPMT deficiency is associated with azathioprine (AZA)-induced myelosuppression (MS). However, in one...
There is a growing interest in the use of thiopurines (azathioprine, 6-mercaptopurine and 6-thioguan...